Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03661671
Other study ID # LCI2018
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2018
Est. completion date January 1, 2019

Study information

Verified date September 2018
Source Changhai Hospital
Contact Dong Wang, M.D
Phone 8613816758802
Email dongwang0901@sina.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

the purpose of this study is to evaluate application value of LCI in the diagnosis of early gastric cancer.


Description:

The detection rate of early gastric cancer is still very low in China. The investigators need a new and effective screening method to improve the detection rate. LCI (linked-color imaging)is a new model of laser endoscopy which can provide brighter image. LCI can provide clear image which can make red part redder and white part whiter, so suspicious lesion could be found easier. The study of this randomized controlled trial is to discuss effectiveness of LCI in the diagnosis of early gastric cancer and to find a new method to improve the detection rate of early gastric cancer in China.


Recruitment information / eligibility

Status Recruiting
Enrollment 2400
Est. completion date January 1, 2019
Est. primary completion date January 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria:

1. High-risk group of gastric cancer: H. pylori infection; previously suffering from chronic atrophic gastritis, intestinal metaplasia, gastric ulcer, gastric polyps, residual stomach after surgery, hypertrophic gastritis, malignant anemia and other precancerous diseases of gastric cancer;

2. First degree relatives of patients with gastric cancer;

3. There are other high risk factors for gastric cancer (high salt, salted diet, smoking, heavy drinking, etc.).

4. Patients with early gastric cancer treated with endoscopic therapy (ESD, EMR).

5. The informed consent has been signed.

Exclusion Criteria:

1. The TNM classification of cancer is consistent with those diagnosed by T2 above.

2. Patients with abnormal blood coagulation function or taking anticoagulants can not biopsy.

3. There were contraindications for gastroscopy.

4. A patient without self judgement;

5. Those who did not sign informed consent.

6. Previous gastroscopy has found suspicious lesions requiring careful examination.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
LCI+white light
Firstly use white light to observe from cardia to duodenum and then switch LCI model to observe from antrum to cardia

Locations

Country Name City State
China Department of Gastroenterology, Changhai Hospital, Second Military Medical University Shanghai Shanghai

Sponsors (14)

Lead Sponsor Collaborator
Changhai Hospital 307 Hospital of PLA, Chongqing University Cancer Hospital, First People's Hospital of Hangzhou, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guilin Medical University, China, Jiangsu Province Hospital of Traditional Chinese Medicine, Shanxi Province Cancer Hospital, The First Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of Nanchang University, Wuhan University, Xi'an Central Hospital, Xiangya Hospital of Central South University, Zhongshan Hospital Xiamen University

Country where clinical trial is conducted

China, 

References & Publications (3)

Fukuda H, Miura Y, Hayashi Y, Takezawa T, Ino Y, Okada M, Osawa H, Lefor AK, Yamamoto H. Linked color imaging technology facilitates early detection of flat gastric cancers. Clin J Gastroenterol. 2015 Dec;8(6):385-9. doi: 10.1007/s12328-015-0612-9. Epub 2 — View Citation

Okada M, Sakamoto H, Takezawa T, Hayashi Y, Sunada K, Lefor AK, Yamamoto H. Laterally Spreading Tumor of the Rectum Delineated with Linked Color Imaging Technology. Clin Endosc. 2016 Mar;49(2):207-8. doi: 10.5946/ce.2015.077. Epub 2016 Feb 12. — View Citation

Sun X, Dong T, Bi Y, Min M, Shen W, Xu Y, Liu Y. Linked color imaging application for improving the endoscopic diagnosis accuracy: a pilot study. Sci Rep. 2016 Sep 19;6:33473. doi: 10.1038/srep33473. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Detection rate of gastric neoplastic lesion Include early gastric caner,high grade dysplasia low grade dysplasia and adenoma immediately following the procedure
Secondary Specificity of detecting gastric neoplastic lesion Include early gastric caner,high grade dysplasia low grade dysplasia and adenoma immediately following the procedure
Secondary Sensitivity of detecting gastric neoplastic lesion Include early gastric caner,high grade dysplasia low grade dysplasia and adenoma immediately following the procedure
See also
  Status Clinical Trial Phase
Terminated NCT04977401 - EndoscoPic Submucosal dIssection Using geL Versus glycerOl for Submucosal iNjection N/A
Not yet recruiting NCT04083573 - Comparison of Diagnostic Performance of Medical Monitor and Medical Augmented Reality Glasses in Endoscopy: Observation Study
Completed NCT02504164 - Effect of Midazolam Premedication on the Satisfaction Levels of Patients After Endoscopic Submucosal Dissection N/A
Recruiting NCT01774266 - Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer N/A
Completed NCT01921283 - Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring N/A
Completed NCT01435525 - Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation N/A
Completed NCT01364324 - Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients
Recruiting NCT03837301 - Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2) Phase 2
Recruiting NCT05269056 - Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
Not yet recruiting NCT03632746 - Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients
Completed NCT01938326 - Pure Single Incision Laparoscopic Distal Gastrectomy (SIDG) Versus Totally Laparoscopic Distal Gastrectomy (TLDG) N/A
Recruiting NCT04602689 - Fibrin Glue After ESD for High Risk Patients of Bleeding N/A
Recruiting NCT05291728 - Screening for Early Gastric Cancer in Shaanxi Province
Not yet recruiting NCT06152783 - Confocal Laser Microendoscopy (CellTouch) for the Diagnosis of Early Gastric Cancer: A Multicenter Clinical Study
Completed NCT02189226 - Usefulness of Probe-based Confocal Laser Endo-microscopy in Delineation of Margin of Early Gastric Cancer for Endoscopic Submucosal Dissection N/A
Completed NCT04602299 - Setting the Shortest Examination Time of Gastroscopy to Improve the Detection Rate of Upper Gastrointestinal Tumors N/A
Completed NCT02562976 - OLGA Stage is More Appropriate in Predicting Early Gastric Cancer N/A
Recruiting NCT01132469 - Efficacy and Safety Study of Endoscopic Submucosal Dissection for Early Gastric Cancer N/A
Completed NCT03136354 - Prospective Randomized Trial Comparing Endoscopic Submucosal Dissection Against Laparoscopic Assisted Gastrectomy for Treatment of Early Gastric Cancer N/A
Completed NCT02216110 - Endoscopic Submucosal Dissection Versus Gastrectomy N/A